2012 May

By Matthew Hill BBC health correspondent

Some analysts suggest that lessons can be learned from Portugal’s drug laws. So how are things done differently there?

As she waited calmly with fellow drug users queuing for their weekly treatment in Lisbon’s main detox centre, Anna was happy to talk about the addiction that has blighted her for the past 15 years.

The 53-year-old drug user, who preferred not to give her surname, said she was now able to lead a normal life because of Portugal’s enlightened approach that favours public health over the criminalisation of drug users.

Anna visits Lisbon’s ‘Centro das Taipas’ each week to receive the heroin substitute methadone.

She explained: “I had a good life, and when I started taking drugs I spoilt my life and now I am drug-free again and I am well. When I feel ok I will stop methadone, if necessary on an in-patient basis.”

The change in law that led to this treatment was a response to a growing drug problem in the late 1990s.

‘No problem’

Portugal had developed a reputation as a gateway for drug trafficking, with more than three quarters of drugs seized destined for other European countries.

By 1999, it had the highest rate of drug-related Aids cases in the EU and there was a growing perception that the criminalisation of drug use was increasingly part of the problem.

So in 2001, the socialist government changed the law to turn possession of drugs into an “administrative offence”, sending those caught with drugs for personal use to a “dissuasion board” rather than face prosecution.

At one of these hearings was a 32-year-old man who had been caught in possession of  hashish.

Paulo showed no regret as he explained his case to a social worker and psychologist, saying: “I don’t feel I have a problem with drugs, so I don’t feel I need to be here”.

As this was his first appearance before the board he was just given a warning. If he is caught again, sanctions will be applied.

But far more drug users are taking up treatment as a result of the change in law, an independent study by Dr Alex Stevens from theUniversity of Kentfound.

It said the overall numbers of drug users in treatment expanded in Portugal from 23,654 to 38,532 between 1998 and 2008. While between 2000 and 2008 the number of case of HIV reduced among drug users from 907 to 267.

“This is a highly significant trend which as been attributed primarily to the expansion of harm reduction services,” it concluded.

Radical change

The advisor of the management board of the Instituto of Drugs in Portugal, Dr Fatima Trigeiros, said its partners had feared decriminalisation would make people flock to Portugal to take drugs, but that did not happen.

“Before the law changed people with drug consumption would fear to come into the treatment structures because they were afraid they would be taken to court,” she said.

Continue reading the main story

“Start Quote

We have a government that on paper at last is a dream ticket for actually putting in place substantive reforms”

End Quote Danny Kushlick Transform

“Also we were not tackling first-time users, those who were experimenting, because the time between being caught and the time they were taken to court was too long. Now they are being taken to the dissuasion boards in 72 hours.”

Would the British government ever entertain such a radical change? The Home Office says decriminalisation is not the answer; instead it wants to reduce drug use and drug-related crime and help addicts kick their habit.

But there is evidence the prime minister thought differently when he was in opposition. Eight years ago, David Cameron wrote in the Daily Telegraph, that “politicians need to get up from behind their barricades and look at what works, rather than what sounds good”.

He called for a declassification of some drugs so cannabis would move from class B to class C and ecstasy from A to B, even allowing some severe heroin users access to injecting rooms.

As a backbench MP, Mr Cameron called on the government to raise a debate at the United Nations on legalisation and regulation. It was the clearest indication ever given by a future British prime minister of a desire to rethink drugs policy.

The charitable think tank “Transform”, which is lobbying for a change in the law, is hoping the prime minister’s past views will prevail.

Its head of external affairs, Danny Kushlick said: “We have a government that on paper at last is a dream ticket for actually putting in place substantive reforms that are going to shift resources from criminal justice and towards public health.”

With difficult public sector cuts looming, drug reform may not be the first priority of the British government, but it is now consulting on the UK Drugs Strategy.

Reformers say if they want to reduce spending on drugs they could do worse than to look to Portugal.

Source  bbc.co.uk/news 3rd Oct.2010

Australians are the world’s highest ecstasy users in the world.
 (Source: U N Office of Drugs and Crime, World Drug Report June 2009).
 
Ecstasy is the second most commonly used illicit drug in Australia.
 (Source: Australian Institute of Health and Welfare 2008)
 
A third of all ecstasy seized globally in 2008 was destined for Australia.
 (Source: International Narcotics Control Board annual report 2010)
 
DRUG ADVISORY COUNCIL COMMENTS-
 
Australia has a culture of illicit drug use which is attracting supply.
 
This culture is supported by policies of syringe distribution, drug maintenance  and drug substitution. Celebrities because of their high public profile highlight this drug culture and the effects on them and their families.
 
Whilst public debate on the effects of illicit drugs is useful, these drugs are
illegal because they are PROVEN dangerous. The violence, mental illness, psychosis and chaos of all illicit drugs are well documented and scientifically proven.
 
The drug culture can only be changed with policies that REDUCE demand and
divert illicit drug users into rehabilitation that produce abstinence from
future use.
 
Court ordered and supervised illicit drug orders should be used to divert all
identified illicit drug users into rehabilitation. Only reduced demand by rehabilitation will starve international criminals of  funds from illicit drugs.
 
THE DRUG ADVISORY COUNCIL OF AUSTRALIA SUPPORTS:

More detoxification & rehabilitation that gets illicit drug user’s drug free.
Court ordered and supervised detoxification & rehabilitation.
Less illicit drug users, drug pushers and drug related crimes.

 
Source:  Drug Advisory Council of Australia  (DACA) August 2010

A 14-YEAR-old manages to get both the Prime Minister and Kevin Rudd’s wife Therese Rein on the phone, and the media flocks to his home in a bid to be the first to tell his side of the story.

This is not a child protege, nor is it a 14-year-old whose talents will deliver Olympic glory.

This Year 9 teenager is a convicted drug felon, having been caught buying 3.6g of marijuana on the streets of Kuta, and the fact that today he is at home is testament to the narrow escape he’s had from the claws of the Indonesian legal system.

His get-out-of-jail-free card is not a good luck charm he is likely to ever try again, but why after all the publicity generated by the cases of Schapelle Corby and the Bali Nine do so many continue to dice with death in Bali?

The answer is two-fold. Firstly, our acceptance of drugs inAustralia has now reached the point where we think it is relatively “normal” for a 14-year-old to have an addiction to a drug he has been smoking for two years.

A 2008 survey of 24,000 Australian high school students found that 14 per cent of students aged 12-to-17 years used cannabis, peaking at 26 per cent for 17-year-olds.

The Australian Secondary Students Alcohol and Drug survey found 80 per cent of pupils between 12 and 17 had tried alcohol. Eleven per cent of 12-year-olds had used inhalants in the previous month, and by the age of 17, seven per cent of students had used amphetamines.

So why would we raise our eyebrows when a 14-year-old Australian school student conducts a drug deal on the streets of Indonesia?

The catch here relates to where he bought the drugs and the penalties for drug-taking inAustralia, compared to our close neighbours – who make no secret of their bid to stamp it out.

Many, perhaps most, Australians are angry at Schapelle Corby’s on-going punishment, believing she has been unfairly treated. Thousands have signed petitions or offered prayers for those members of the Bali Nine who decided to wrap drugs to their bodies and smuggle it back home. Didn’t they think that other young Australians would use it – and possibly die?

Instead of ongoing outrage, we sympathise with those caught and point the finger of blame at Indonesia.

We have to change that psyche. Drugs are deadly. And in Indonesia the punishment for using them can be deadly too. It’s not a secret. And disagreeing with it doesn’t change it. In fact, in this part of the world,Australia is the odd one out, with other countries mirroring Indonesia’s stance.

So if we are serious about tackling drug use, we need to look at whether we should be ridiculing another country’s policy, or adopting tougher penalties here. Instead, we give movie-star status to a teenager who should know better. We protect him getting from the airport to his home, we don’t use his name, and his family breathes a sigh of relief that he’s relatively unscathed “considering what he went through”.

The next 14-year-old won’t receive the same easy ride, and this one is lucky authorities did not want to make an example of him – particularly at a time when we are laying down tough laws netting Indonesian teenagers lured into people-smuggling rackets in a bid to feed their families.

The problem with drugs is not Indonesia, or how it punishes users. The problem is with us, and how we have “normalised” drug use here – to the point where we’re told experimentation is typical in teenage years. To that extent, it’s not this lad’s fault either. The problem is bigger than he is, and will only grow while we accept its use and refuse to confront the consequences. The Courier-Mail spelt this out graphically in its Drug Scourge investigation, which showed greater crime, a bigger road toll and increasing mental health issues.

Several weeks ago on the Gold Coast, I walked into the female toilets used by diners of an upmarket restaurant to see a well-dressed young man sniffing cocaine off a toilet seat. He apologised – for using the female toilet not the drug-taking – and continued on his high. No shame, but is there any wonder?

Source:  Courier Mail Australia.  Dec. 2011 

mk@madonnaking.com.au.
On Twitter: @madonnamking

A rebuttal of information by John Stossel of  Fox News.  2nd March  2012

Mr Stossel. You are welcome to publish my response if you wish.

Your article about drugs is not backed up by the evidence, there is plenty of scope for drugs use to increase under a change of system where drugs use is normalised (either decrimininalisation or various legalization models). The evidence is in the tobacco/alcohol model /as variously applied/ around the world. Tobacco and alcohol cause far more /total harm/ than the illegal drugs simply through prevalence.

Your remarks about Portugal are not supported by a critical examination of what has taken place there. All the hyperbole about Portugal as a model is based on one flawed study, assiduously reported around the world as a “meme” by the George Soros financed, world-wide, legalisation campaign. You have been hoodwinked. Not surprising really, millions of dollars have been spent to do that to you.

Portugal and decriminalisation appears now to be “the new orthodoxy” for those with a certain direction of travel and for those “user advocates” who want more freedom to use, regardless of the wider social effects.

Portugal is being misrepresented

1. The number of new cases of HIV and Hepatitis C inPortugalis eight times the average in other EU countries

2.Portugal has the most cases of injected drug related AIDS with 85 new cases per one million citizens. Other EU countries averaging 5 per million.

3. Since decriminalisation, drug related homicides have increased 40%.

4. Drug overdoses have increased substantially, over 30% in 2005

5. There has been an increase of 45% in post mortems testing positive for illegal drugs

6. Amphetamine & cocaine consumption has doubled in Portugal with cocaine seizures increasing sevenfold between 2001 and 2006.

Finally the suggestion made by some, that legalisation would somehow remove criminality from drug supply is ridiculous. Criminality loves use-reinforcing substances and behaviours. More than 20% of the UK tobacco market is smuggled, counterfeit, or both. In some other countries it is much worse.

Legalisation or decriminalisation, of substances unfit for human consumption, should only occur if a demonstrable “public good” can be evidenced.

The problem for the legalisation lobby is that it cannot.

 

David Raynes.

Member. International Task force on Strategic Drug Policy

http://www.itfsdp.org/members.php

 

 

Filed under: Cocaine,Europe,Legal Sector :

“It’s extraordinarily simplistic for the Global Commission to advocate that decriminalising drugs will lead to reduced addiction rates and less crime.  The idea that drug abuse is a victimless crime is also hugely over-simplifying things.

In Scotland there is a huge problem with drug addiction and this has become dramatically worse over recent decades. Such is the scale of the problem now that we have a detection rate of just 1 per cent of all the heroin that’s consumed in Scotland.

That’s a figure we should be hugely discomforted by and it gives us an idea of the scale of the problem we’re facing. The Global Commission’s recommendations seem to have given up on the idea of getting addicts off drugs and seem to be accepting it’s a problem that’s here to stay.

As things stand, we are already leaving too many addicts for too long on methadone, for example. We need to have a policy of supporting people to move from increased stability to abstinence. Legalising drugs would open the floodgates to more drugs problems and would be a catastrophe for the country.

There are areas in Scotland where drug use is already rife, such as some estates in the cities of Edinburgh and Glasgow. If drugs were no longer illegal this would spread rapidly and get out of all control very quickly, we would end up with a drug problem that’s of a similar scale to the one we currently have with alcohol.

The policy advocated by the Global Commission would also lead to higher levels of crime and would corrupt the economy, and there would be huge economic power left with these businesses selling drugs. The power of the drugs gangs would remain in place, but they would now be legitimate in the eyes of the law and would be more likely to diversify into other areas of crime.

We would also see some companies that are currently legitimate corrupted by their involvement in the drugs trade. This has already happened in Columbia, where the gangs have become more powerful and have influence over more parts of society.

Drug dealers and organised crime would all of a sudden have so much more influence and this would be hugely damaging to Scottish society as a whole. We have to look at how to solve the problems with drugs in a much more measured way and that means having joined up strategies in place to treat addicts, as well as an effective criminal justice system.

One of the biggest problems of all though is that we have become too accustomed to having a drug problem in Scotland over the past 20 years and have allowed the problem to get worse and worse. The last thing we want is any sort of knee-jerk reaction or a rushed decision that has come up with all the wrong sorts of ideas. Prevention of drug addiction through education and early intervention have got to be at the heart of any anti-drugs strategy.

But we need to be very clear that a 1 per cent detection rate for all the heroin use in Scotland is just not acceptable and needs to be dramatically improved.  The approach put forward by the Global Commission is certainly not the route to go down, as it would just escalate our problems with crime and addiction.

If we imagine just how bad things have become in Scotland with drug addiction and crime, we should stop to think how much worse they could be if these proposals to decriminalise drugs are introduced.  The crisis could get much worse unless we have a sensible approach that gets to the heart of the problem”.

lNeil McKeganey is a professor of drug misuse research at the University of Glasgow

Source: Scotsman.com 2nd June 2011

A United Nations panel today agreed on a set of measures to prevent the use of illicit drugs and strengthen national and regional responses, including using treatment instead of incarceration to stem a worrying global trend in the abuse of narcotics.

Wrapping up its week-long 55th session in Vienna, the Commission on Narcotic Drugs (CND), adopted 12 resolutions, including on the treatment, rehabilitation and social reintegration of drug-dependent prisoners; treatment as an alternative to incarceration; and preventing death from overdose.

The commission, which is made up of 53 member States, underlined the need for gender-specific interventions and called for the promotion of drug prevention, treatment and care for female drug addicts. It also called for more evidence-based strategies to prevent the use of illicit drugs, especially among young people.

Yury Fedotov, the Executive Director of the UN Office on Drugs and Crime (UNODC), hailed the fundamental role of existing international drugs conventions in safeguarding public health.

“It is only by acknowledging the drug conventions as the foundation for our shared responsibility that we can make successive generations safe from illicit drugs,” he said.

The commission acknowledged the role played by developing countries in sharing best practices, including through continental and inter-regional cooperation to promote alternative development programmes in poor rural communities dependent on the cultivation of illicit drug crops.

One of the new issues that emerged during the current session is the increasing diversion of chemicals to manufacture illicit amphetamine-type stimulants, a group of synthetic drugs that includes ecstasy and methamphetamine.

The commission called for international cooperation to curb the manufacture of new psychoactive substances. It also recommended the development of an international electronic authorization system for the trade in controlled substances.

This year’s session drew some 1,200 participants from 120 countries, observers, international organizations and non-governmental organizations.

Source:www.un.org 16th March

As a leader of a nationally prominent anti-drug coalition in San Diego County, I was thoroughly disappointed with the California Medical Association’s recent report endorsing marijuana legalization as a way to speed research into medical marijuana. Unfortunately, the CMA conflated those two very different issues by recklessly supporting the risky proposition of legalization.

First, it is important to discuss the disastrous impact marijuana legalization would have on our state. Marijuana is illegal because it is dangerous – not dangerous because it’s illegal. Recent studies link the drug with cognitive impairment (think memory loss and other brain dysfunction), motor skills impairment (think drugged driving accidents), and mental illness (like psychosis and schizophrenia). Indeed, marijuana negatively impacts the development of the adolescent brain, which is still maturing until about age 25.

We also know, according to a recent RAND report, that the price of marijuana would fall dramatically if it were legalized. Our experience with alcohol and tobacco tells us that lower price means greater use and addiction rates. And while about 1 in 10 adults who ever start marijuana will become dependent on it, according to the National Institutes of Health, that number jumps to between 1 in 4 and 1 in 2 when the drug is initiated in adolescence. Calling for legalization for adults only and thinking it will prevent drug use among kids is naive and dangerous – just ask any kid who has easy access to alcohol and tobacco today, despite age limits.

Finally, marijuana tax revenues would pale in comparison to the social costs of the increased use of the drug. Again, our two legal drugs, alcohol and tobacco, can be used as a reference point – they bring in about one-tenth of the social costs they produce.

That one opposes legalization does not mean that one has to be all for the status quo. Indeed, we need to invest more into prevention programs to stop marijuana use before it starts, intervene on early use, and treat marijuana addiction.

Nor does opposition to legalization signal acrimony toward increased medical research into the individual components of marijuana. This is where CMA makes its mistake. The organization reasoned that legalization is the only way to achieve this kind of research. And it is wrong.

Research into the active ingredients of marijuana – and there are hundreds of them – is an important area of science that should be explored. Indeed, today we have two such drugs derived from marijuana and the FDA is currently exploring others, like Sativex. Sativex is a tongue spray that is comprised of the active ingredient in marijuana – THC – and another ingredient called CBD. The THC in marijuana is what gets someone “high,” and the CBD counteracts that so that the drug is not dangerous or dependence-inducing. Late-stage trials of the drug show promise for spasticity related to multiple sclerosis and pain related to cancer. It has been approved in other countries for these purposes, too.

The bottom line is that one of CMA’s core arguments is a myth – that the government’s prohibition of marijuana prevents proper investigation into the drug’s therapeutic properties. The National Institute on Drug Abuse grows marijuana, in several different strains and varieties, for this exact purpose. According to the Drug Enforcement Administration, which issues licenses to deal with marijuana for research purposes, over 200 researchers have access to the drug.

So it is unfortunate that the California Medical Association – representing only a small number of their doctors who pushed a legalization position from the start – is now mixing politics with science. Advocating for legalization as the only route to research not only displays an ignorance of the drug-approval process, but it also represents a platform that will have untold consequences from a profession that should, first and foremost, “do no harm.”

Source:  www.signonsandiego.com  6th Nov 2011

November 23, 2011

Medical Marijuana: The Government’s View

To the Editor:

In his Nov. 7 Op-Ed article, “Reefer Madness,” Ethan Nadelmann criticized the Obama administration’s position on medical marijuana and described the debate as “essentially a cultural and political struggle.”

The issue of medical marijuana is not about culture and counterculture. It is not a struggle; it is not a war. It simply comes down to how we approve medications as safe and effective for use in theUnited States. To date, the Food and Drug Administration has not found smoked marijuana to be either safe or effective medicine for any condition.

No national medical association has come out in favour of smoked marijuana for widespread medical use. Further, many public health organizations, including the American Cancer Society, American Glaucoma Foundation, National Pain Foundation and National Multiple Sclerosis Society, do not support smoked “medical” marijuana.

The administration’s position is clear: the medication approval process should remain above the political fray. Smoked marijuana does not meet scientific standards for safe and effective medicine, and marijuana use and distribution remain illegal under federal law for any purpose.

Like our National Drug Control Strategy, it is a position driven by evidence, not ideology. When it comes to protecting public health and public safety, the American people deserve no less.

RAFAEL LEMAITRE
Associate Director for Public Affairs
Office of National Drug Control Policy
Washington, Nov. 14, 2011

Filed under: Drug Specifics,USA :

The British Liver Trust however says the number now being admitted to hospitals because of alcohol is a big problem for the country and blames the problem on a combination of cheap drink and extended drinking times.

The charity figures show that more than 500 people a day are being admitted to hospital because of alcohol-induced accidents, violence and liver damage and the number of alcohol-related hospital admissions has increased by almost a third since the licensing laws were relaxed almost two years ago.

According to NHS statistics the highest number is in the North East. NHS statistics show that in 2003-04 there were 147,659 admissions to English hospitals where alcohol was given as a cause.

In 2005-06, when the drinking laws were relaxed, the total was 193,637, or 530 admissions a day.

Source:News-Medical.net 2nd Jan.2008

Next November, Californians will ballot on allowing people 21 years and older to possess, cultivate and transport cannabis for personal use, as well as enable its commercial production and sale. Professor Keith Humphreys of Stanford University School of Medicine’s psychiatry and behavioural sciences departments, discusses the potential consequences.

He recently returned to Stanford after a one-year stint in the White House as a senior adviser on national drug control policy – and was a key speaker at the UK/European Symposium on Addictive Disorders inLondon last May.

Click here for related facts, also CannabisSkunk Support

Q: There are estimates that, with legalisation, marijuana use could rise 50-100 percent%. Are those projections reasonable?

Humphreys: We know very well from other commodities that if you make something illegal, the price of it goes up. And when you make it legal, it becomes much cheaper. So the findings are credible. Why they’re scary is that big drops in price tend to affect mainly people with less disposable income…teenagers, the unemployed, other people who have just a small amount of extra money. This will drop marijuana to something they could easily afford to do on a daily basis.

It is not just legalising consumption; it is legalising production. That means you’re going to have an industry, like the tobacco industry, that will have lobbyists and marketers and lots of money. In fact, I wonder if tobacco companies might go into this business. They are well-positioned. They have the outlets and the pricing power. It will become a mass-produced, very cheap product.

Q: But the proposition also allows people to grow their own marijuana…

Humphreys: For the vast majority of people, if there’s a refined product in a nice package down at the store that costs 1/10th as much, and you don’t have to water or worry about sunlight, then they will buy it.

Q: What about the argument that taxing marijuana will provide much-needed revenue?

Humphreys: We should be legalising child pornography and human trafficking? There’s lots of awful things that raise money, and that doesn’t make them right. The second point is that taxes never recoup the harm from substances. If you look at all estimates of alcohol and tobacco taxation, it never even touched a fifth of the amount of health damage. So you get a little money in the short term, but in the long term, someone’s got to pay for car accidents and kids flunking out of school and things like that.

Q: What about the notion that by legalising it you take it out of clandestine operations?

Humphreys: You will probably get rid of some gun violence, for example. But look at the example of a tobacco company. You could have substantially more death. There’s lots of ways to do violence in this world. You can weaken government regulations in a way that results in thousands of people dying.

In terms of its medical use, I have compassion for patients; I was a hospice worker for many years. But I don’t feel that’s the typical person getting medical marijuana. A paper in the Harm Reduction Journal that profiled about 4,000 such people said the prototypical patient was a 30-year-old male who had been smoking pot for about 15 years and wasn’t seriously ill – that group is riding on our compassion for the people who have Aids, MS or cancer.

To me, it’s a pretty big jump to go from saying that this plant has some medical value, to saying that its consumption — and also its production and advertising — should be legalised.

Source:    Addiction Today   August 6th2010

The continued push in the USA  for marijuana to be legalised ‘for medicinal purposes’ has resulted in many States allowing the substance to be sold in so-called ‘marijuana dispensaries’.  However closer investigation has shown the majority of people purchasing the substance are not those with serious and even terminal illnesses, but existing drug users wanting to justify their purchase and use.  They are able to get co-operative doctors to sign a form saying that they need to use marijuana to help with ‘back pain or headaches’ or similar trivial illnesses.  The item below shows that as far back as l989 it was shown that for genuinely ill patients a pharmaceutically prepared  drug called Marinol (or Nabilone) could be legally prescribed by a doctor if it was shown to be helpful – without the many drawbacks to smoking crude marijuana. There is now a pharmaceutically prepared medicine made from extracts of marijuana called Sativex and there is therefore no need for anyone to smoke marijuana for medicine. 
 
Rescheduling of Marijuana Denied (1989)
During the late 1980s, as a proposed solution to the enormous drug problem in the United States, a small, but vocal minority began supporting the wholesale legalization of drugs, particularly marijuana. However, in December 1989, DEA Administrator Jack Lawn overruled the decision of one administrative law judge who had agreed with marijuana advocates that marijuana should be moved from Schedule I to Schedule II of the Controlled Substances Act. This proposed rescheduling of marijuana would have allowed physicians to prescribe the smoking of marijuana as a legal treatment for some forms of illness.
Administrator Lawn maintained that there was no medicinal benefit to smoking marijuana. While some believed that smoking marijuana alleviated vomiting and nausea experienced by cancer patients undergoing radiation, scientific studies indicated otherwise. These also showed that smoking marijuana did not benefit patients suffering from glaucoma or multiple sclerosis. In addition, it was found that smoking marijuana might further weaken the immune systems of patients undergoing radiation and might speed up, rather than slow down, the loss of eyesight in glaucoma patients. It was found that pure Delta-9-Tetrahydrocannabinol (THC), one of 400 chemicals commonly found in marijuana, had some effect on controlling nausea and vomiting. However, pure THC was already available for use by the medical community in a capsule form called Marinol. For these reasons, and the fact that no valid scientific studies offered proof of any medicinal value of marijuana, Administrator Lawn maintained that marijuana should remain a Schedule I controlled substance.
Early adolescent cannabis use may contribute to the development of symptoms of schizotypal personality disorder (SPD) in adulthood, according to new data from a longitudinal cohort study.
“The uniqueness of this study lies in the demonstration of an association between early cannabis use and subsequent schizophrenia-like symptoms that persisted into adulthood and that was not explained by early anxiety or depressive disorders, or exposure to other drug and cigarette use,” study author Deidre M. Anglin, PhD, assistant professor of clinical psychology, City College and Graduate Center, City University of New York, told Medscape Medical News.
“In addition, this study adds to the literature by demonstrating that this association was not only limited to those already exhibiting higher levels of these symptoms during childhood and adolescence,” she added.  The study is published in the May issue of Schizophrenia Research.
Mounting evidence indicates that cannabis use is temporally associated with the development of schizophrenia in some young people, but less is known about its relationship to latent SPD traits. SPD symptoms are characterized by attenuated psychotic symptoms that include unusual perceptual experiences and beliefs and odd and withdrawn behavior.
To investigate, Dr. Anglin and colleagues analyzed prospective data on 804 participants enrolled in the longitudinal Children in the Community cohort study from upstate New York.
As part of the study, participants were assessed for cannabis use and Axis I and II disorders, beginning at a mean age of 13 years (range, 9 – 18 years), and again at around the ages of 16, 22, and 33 years.
During the 3 assessments, about 70% of participants (n = 567) reported ever using cannabis; the majority reported experimental or rare use. Only 17% (n = 97) reported early cannabis use, defined as regular use before the age of 14 years.
These early users were significantly more likely than nonusers to use other drugs (19% vs 2%) and to smoke cigarettes (86% vs 36%); they were also more likely to have major depression (9% vs 4%) but not anxiety disorder (23% vs 27%). Early cannabis users had only a “slightly higher” mean level of SPD symptoms.
The researchers report that cannabis use before the age of 14 years “strongly predicted” schizotypal symptoms in adulthood, independent of early adolescent schizotypy, major depression, anxiety, other drug use, and cigarette use. Over the trajectory, early cannabis users demonstrated higher levels of SPD symptoms (.24 SD unit difference, Cohen’s d, P < .01) than nonusers.
Importantly, they note, the effect of early cannabis use on SPD symptoms into adulthood was not restricted to those already showing SPD symptoms in adolescence or to those with signs of depression or anxiety or use of other drugs or cigarettes.
Large Body of Evidence 
This study, said Dr. Anglin, adds to “the large body of evidence relating cannabis use with psychosis by demonstrating that cannabis use occurring earlier in development may also play a role in the development of subthreshold schizophrenia-like symptoms.”
Study coauthor Cheryl Corcoran, MD, from the New York State Psychiatric Institute and Columbia University, in New York City, told Medscape Medical News what is “truly noteworthy is that cannabis use may play a role in the formation of schizophrenia symptoms beyond psychotic symptoms, such as its characteristic oddness and negative symptoms of low motivation and low social drive.”
“From an epidemiological perspective, this study was well done and controlled for important potential confounds, including earlier symptoms, depression, anxiety, other drug use, and cigarette smoking,” Dr. Corcoran added.
Reached for comment, Wayne Hall, PhD, from the University of Queensland Centre for Clinical Research in St. Lucia, Australia, who was not involved in the study, told Medscape Medical News that the results are “largely confirmatory of the literature.”
The authors note that additional research is needed to determine the underlying mechanisms for the association of early cannabis use and SPD symptoms and to determine whether these effects of using cannabis on SPD symptoms vary with duration of use throughout the life course.
It is unclear, the study authors add, “whether the effects of early cannabis use are minimized among those who stop smoking at some other developmentally critical point (eg, in their early 20s or even later).”
Source   http://www.medscape.com/viewarticle/764024   May 2012 Schizophrenia Res. 2012;137:45-49
The smoking ban in public places has led to a reduction in the number of complications in pregnancy, a new study has found.  Complications in pregnancy have fallen as a result of the ban on smoking in public places, according to a new study.
Researchers found the ban, introduced almost six years ago, has led to a decrease in the number of babies being born before they reach full term.  It has also reduced the number of infants being born underweight.
Legislation outlawing smoking in enclosed public places, such as pubs and restaurants, came into force in Scotland on March 26 2006.  The research team, led by Professor Jill Pell of the University of Glasgow’s Institute of Health and Wellbeing, looked at more than 700,000 single-baby births before and after the introduction of the ban.   They discovered that the number of mothers who smoked fell from 25.4% to 18.8% after the new law was brought in.
Experts further found there was a drop of more than 10% in the overall number of babies born “preterm”, which is defined as delivery before 37 weeks’ gestation. There was also a 5% drop in the number of infants born under the expected weight, and a fall of 8% in babies born “very small for gestational size”.
Dr Pell said the research highlighted the positive health benefits which can stem from tobacco control legislation.  She said: “These findings add to the growing evidence of the wide-ranging health benefits of smoke-free legislation and support the adoption of such legislation in other countries which have yet to implement smoking bans.
“These reductions occurred both in mothers who smoked and those who had never smoked. While survival rates for preterm deliveries have improved over the years, infants are still at risk of developing long-term health problems so any intervention that can reduce the risk of preterm delivery has the potential to produce important public health benefits.”
Source:    pa.press.net Updated: 07/03/2012
Filed under: Health,Parents :

As professionals in the business of preventing and treating substance abuse, we at Trinity County Behavioral Health Services spend a good deal of our time researching and reading current science based literature and studies on the addictive nature of substances in order to better treat clients. For us, it is important to dispel the myth that marijuana is not addictive.

Research on marijuana use and addiction has been ongoing for many years and it has been proven that marijuana is an addictive drug. It is classified as a Schedule 1 controlled substance. Marijuana is the most commonly abused illicit drug used in the United States and addiction to this drug is listed under the Diagnostic and Statistical Manual of Mental Disorders as Cannabis Dependence (304.30). The main active chemical of marijuana causing dependence is delta-9-tetrahydrocannabinol, otherwise known as THC.

A favorite DVD we use here at Behavioral Health Services in treating our marijuana addicted clients is “Marijuana Neurochemistry and Physiology” produced by CNS Production. In this DVD, Haight- Ashbury Free Clinic (HAFC) Fellow and Doctor of Pharmacy Darryl Inaba discusses the addictive nature of marijuana. According to Dr. Inaba, in the late 1960s and through the ‘70s, the HAFC rarely (if at all) treated clients for marijuana addiction. But this changed in the late 80s and into the 90s as THC levels in marijuana began to climb sharply (a 151 percent increase in potency between 1992 and 2002). According to Dr. Inaba, in 2005 HAFC saw about 100 people per month seeking treatment for marijuana addiction alone and aside from any other drug use.

Dr. Inaba’s observation confirms what research is telling us about both psychological and tissue dependence caused by today’s “new,” more potent hybridized marijuana strains. These new marijuana strains have had some of the biggest impacts on our youth. Substance Abuse and Mental Health Services Administration treatment episodes data show that between 1992 and 2002 treatment for marijuana cannabis dependence among adolescents increased from 23 percent to 64 percent respectively — increasing right along with average THC levels over that time period. Parents need to know that today’s marijuana is very different than when they were teens. In many ways it is no longer a “gateway drug,” but the drug of choice and with the increased potency come increased addiction rates.

Should marijuana one day be legalized, we hope that the marijuana industry will have a better social consciousness than society has experienced with the alcohol and tobacco industries, the two industries marijuana proponents most compare in justifying legalization of marijuana. Alcohol and tobacco have never been taxed at a rate high enough to compensate for the tremendous harm they have caused. It has been our experience that when such industries profit by more consumption, they rarely educate the end users about the true negative consequences of using their products, something we see happening now with the promotion of marijuana as a “benign and harmless natural herb.”

Source: http://www.trinityjournal.com/news/2010-02-17/Opinion/Todays_more_potent_marijuana_can_be_addictive.html

When it comes to prevention of substance use in our “tween” population, turning kids on to ‘thought control’ may just be the answer to getting them to say no, Medical News Today reports.

New research published in the Journal of Studies on Alcohol and Drugs, co-led by professors Roisin O’Connor of Concordia University and Craig Colder of State University of New York at Buffalo, has found that around the” tween-age” years, youth are decidedly ambivalent toward cigarettes and alcohol. It seems that the youngsters have both positive and negative associations with these harmful substances and have yet to decide one way or the other. Because they are especially susceptible to social influences, media portrayals of drug use and peer pressure become strong allies of substance use around these formative years.

“Initiation and escalation of alcohol and cigarette use occurring during late childhood and adolescence makes this an important developmental period to examine precursors of substance use,” O’Connor said. “We conducted this study to have a better understanding of what puts this group at risk for initiating substance use so we can be more proactive with prevention.”

The study showed that at the impulsive, automatic level, these kids thought these substances were bad but they were easily able to overcome these biases and think of them as good when asked to place them with positive words. O’Connor explains that “this suggests that this age group may be somewhat ambivalent about drinking and smoking. We need to be concerned when kids are ambivalent because this is when they may be more easily swayed by social influences.”

According to O’Connor, drinking and smoking among this age group is influenced by both impulsive (acting without thinking), and controlled (weighing the pros against the cons) decisional processes. With this study, both processes were therefore examined to best understand the risk for initiating substance use.

To do this, close to 400 children between the ages of 10 and 12 participated in a computer-based test that involved targeted tasks. The tweens were asked to place pictures of cigarettes and alcohol with negative or positive words. The correct categorization of some trials, for example, involved placing pictures of alcohol with a positive word in one category and placing pictures of alcohol with negative words in another category.

The next step in the study is to look at kids over a longer period of time. The hypothesis from the research is that as tweens begin to use these substances there will be an apparent weakening in their negative biases toward drinking and smoking. The desire will eventually outweigh the costs. It is also expected that they will continue to easily outweigh the pros relative to the cons related to substance use.

O’Connor said researchers would like to continue to track the youth, who, he said, know that drugs are inherently bad.

“The problem is the likelihood of external pressures that are pushing them past their ambivalence so that they use. In a school curriculum format I see helping kids deal with their ambivalence in the moment when faced with the choice to use or not use substances,” O’Connor concluded.

Source:www.cadca.org 15th March 2012

Adolescents’ use of marijuana may increase the risk of heroin addiction later in life, a new study suggests. Researchers say the work adds to “overwhelming” evidence that people under 21 should not use marijuana because of the risk of damaging the developing brain.

The idea that smoking cannabis increases the user’s chance of going on to take harder drugs such as heroin is highly contentious. Some dub cannabis a “gateway” drug, arguing that peer pressure and exposure to drug dealers will tempt users to escalate their drug use. Others insist that smoking cannabis is unrelated to further drug use.

Now research in rats suggests that using marijuana reduces future sensitivity to opioids, which makes people more vulnerable to heroin addiction later in life. It does so by altering the brain chemistry of marijuana users, say the researchers.

“Adolescents in particular should never take cannabis – it’s far too risky because the brain areas essential for behaviour and cognitive functioning are still developing and are very sensitive to drug exposure,” says Jasmin Hurd, who led the study at the Karolinska Institute in Sweden.
But Hurd acknowledges that most people who use cannabis begin in their teens. A recent survey reported that as many as 20% of 16-year-olds in the US and Europe had illegally used cannabis in the previous month.

“Teenage” rats

In order to explore how the adolescent use of cannabis affects later drug use, Hurd and colleagues set up an experiment in rats aimed to mirror human use as closely as possible.

In the first part of the trial, six “teenage” rats were given a small dose of THC – the active chemical in cannabis – every three days between the ages of 28 and 49 days, which is the equivalent of human ages 12 to 18. The amount of THC given was roughly equivalent to a human smoking one joint every three days, Hurd explains. A control group of six rats did not receive THC.

One week after the first part was completed, catheters were inserted in all 12 of the adult rats and they were able to self-administer heroin by pushing a lever.
“At first, all the rats behaved the same and began to self-administer heroin frequently,” says Hurd. “But after a while, they stabilised their daily intake at a certain level. We saw that the ones that had been on THC as teenagers stabilised their intake at a much higher level than the others – they appeared to be less sensitive to the effects of heroin. And this continued throughout their lives.”

Hurd says reduced sensitivity to the heroin means the rats take larger doses, which has been shown to increase the risk of addiction.

Drug memory

The researchers then examined specific brain cells in the rats, including the opioid and cannabinoid receptors. They found that the rats that had been given THC during adolescence had a significantly altered opioid system in the area associated with reward and positive emotions. This is also the area linked to addiction.

“These are very specific changes and they are long-lasting, so the brain may ‘remember’ past cannabis experimentation and be vulnerable to harder drugs later in life,” Hurd says.
Neurologist Jim van Os, a cannabis expert at the University of Maastricht in the Netherlands told New Scientist the research was a welcome addition to our understanding of how cannabis affects the adolescent brain.

“The issue of cross-sensitisation of cannabis/opioid receptors has been a controversial one, but these findings show the drug’s damaging effects on the reward structures of the brain,” van Oshe says. “There is now overwhelming evidence that nobody in the brain’s developmental stage – under the age of 21 – should use cannabis.”

Source: On line edition of Neuropsychopharmacology. Reported in NewScientist.com July 2006

• Young people in the UK have by far the most positive expectations of alcohol in Europe and are least likely to feel that it might cause them harm.
• Exposure to alcohol marketing increases the likelihood that young people will start to use alcohol and the amount they consume.
• The alcohol industry spends £800 million on marketing in the UK annually
• A spends £153 encouraging drinking per £1 contributed to Drinkaware – the industry led alcohol information organisation charged with promoting sensible drinking.
• Underage drinkers consume approximately the equivalent of 6.9 million pints of beer or 1.7 million bottles each week
• 630,000 11- to 17-year-olds drink twice or more each week.
• Between 2002 and 2009 – 92,220 under-18s were admitted to hospital in England for alcohol-related conditions- over 36 children or young people each day.
• Under-18s alcohol-related hospital admissions increased by 32% between 2002 and 2007.
• The latest European School Survey Project on Alcohol and Other Drugs reported that in the UK 26% of 11-15 year-olds reported suffering an accident or injury because of their drinking, the highest percentage in Europe.
• Although cases of dependence amongst underage drinkers are rare, in 2008/9 – 8,799 younger people accessed treatment for alcohol up from 4,886 in 2005/6.

Source:www.alcoholconcern.org.uk Nov.2011

Position Statement – December 2011

The flawed proposition of drug legalisation

Various well funded pressure groups have mounted campaigns to overturn the United Nations Conventions on drugs. These groups claim that society should accept the fact of drugs as a problem that will remain and, therefore, should be managed in a way that would enable millions of people to take advantage of an alleged ‘legal right’ to use drugs of their choice.

It is important to note that international law makes a distinction between “hard law” and “soft law.” Hard law is legally binding upon the States. Soft law is not binding. UN Conventions, such as the Conventions on Drugs, are considered hard law and must be upheld by the countries that have ratified the UN Drug Conventions.

International narcotics legislation is mainly made up of the three UN Conventions from 1961 (Single Convention on Narcotic Drugs), 1971 (Convention on Psychotropic Substances), and 1988 (Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances):

• The 1961 Convention sets out that “the possession, use, trade in, distribution,import, export, manufacture and the production of drugs is exclusively limited to medical and scientific purposes”. Penal cooperation is to be established so as to ensure that drugs are only used licitly (for prescribed medical purposes).

• The 1971 Convention resembles closely the 1961 Convention, whilst
establishing an international control system for Psychotropic Substances.

• The 1988 Convention reflects the response of the international community to increasing illicit cultivation, production, manufacture, and trafficking activities. International narcotics legislation draws a line between licit (medical) and illicit (non-medical) use, and sets out measures for prevention of illicit use, including penal measures. The preamble to the 1961 Convention states that the parties to the Convention are “Recognizing that addiction to narcotic drugs constitutes a serious evil for the individual and is fraught with social and economic danger to mankind”. The Conventions are reviewed every ten years and have consistently been upheld.

The UN system of drug control includes the Office of Drugs and Crime, the International Narcotics Control Board, and the Commission on Narcotic Drugs. The works of these bodies are positive and essential in international drug demand and supply reduction. They are also attacked by those seeking to legalise drugs.

It is frequently and falsely asserted that the so-called “War on Drugs” is inappropriate and has become a very costly and demonstrable failure. It is declared by some that vast resources have been poured into the prevention of drug use and the suppression of illicit manufacturing, trafficking, and supply. It is further claimed that what is essentially a chronic medical problem has been turned into a criminal justice issue with inappropriate remedies that make “innocent” people criminals. In short, the flawed argument is that “prohibition” monies have been wasted and the immeasurable financial resources applied to this activity would be better spent for the general benefit of the community.

The groups supporting legalisation are: people who use drugs, those who believe that the present system of control does more harm than good, and those who are keen to make significant profits from marketing newly authorised addictive substances. In addition to pernicious distribution of drugs, dealers circulate specious and misleading information. They foster the erroneous belief that drugs are harmless, thus adding to even more confused thinking.

Superficially crafted, yet pseudo-persuasive arguments are put forward that can be accepted by many concerned, well intentioned people who have neither the time nor the knowledge to research the matter thoroughly, but accept them in good faith. Frequently high profile people claim that legalisation is the best way of addressing a major social problem without cogent supporting evidence. This too influences others, especially the ill informed who accept statements as being accurate and well informed. Through this ill-informed propaganda, people are asked to believe that such action would defeat the traffickers, take the profit out of the drug trade and solve the drug problem completely.

The total case for legalisation seems to be based on the assertion that the government assault on alleged civil liberties has been disastrously and expensively ineffective and counter-productive. In short, it is alleged, in contradiction to evidence, that prohibition has produced more costs than benefits and, therefore, the use of drugs on a personal basis should be permitted. Advocates claim that legalisation would eliminate the massive expenditure incurred by prohibition and would take the profit out of crime for suppliers and dealers. They further claim that it would decriminalise what they consider “understandable” human behaviour and thus prevent the overburdening of the criminal justice system that is manifestly failing to cope. It is further argued irrationally that police time would not be wasted on minor drug offences, the courts would be freed from the backlog of trivial cases and the prisons would not be used as warehouses for those who choose to use drugs, and the saved resources could be used more effectively.

Types of drug legalisation

The term “legalisation” can have any one of the following meanings:

1. Total Legalisation – All illicit drugs such as heroin, cocaine, methamphetamine, and marijuana would be legal and treated as commercial products. No government regulation would be required to oversee production, marketing, or distribution.

2. Regulated Legalisation – The production and distribution of drugs would be regulated by the government with limits on amounts that can be purchased and the age of purchasers. There would be no criminal or civil sanctions for possessing, manufacturing, or distributing drugs unless these actions violated the regulatory system. Drug sales could be taxed.

3. Decriminalisation – Decriminalisation eliminates criminal sanctions for drug use and provides civil sanctions for possession of drugs. To achieve the agenda of drug legalisation, advocates argue for:

• legalising drugs by lowering or ending penalties for drug possession and use – particularly marijuana;

• legalising marijuana and other illicit drugs as a so-called medicine;
• harm reduction programmes such as needle exchange programmes, drug injection sites, heroin distribution to addicts, and facilitation of so-called safe use of drugs that normalize drug use, create the illusion that drugs can be used safely if one just knows how, and eliminates a goal of abstinence from drugs;

• legalised growing of industrial hemp;
• an inclusion of drug users as equal partners in establishing and enforcing drug policy; and

• protection for drug users at the expense and to the detriment of non-users under the pretence of “human rights.”

The problem is with the drugs and not the drug policies

Legalisation of current illicit drugs, including marijuana, is not a viable solution to the global drug problem and would actually exacerbate the problem. The UN Drug Conventions were adopted because of the recognition by the international community that drugs are an enormous social problem and that the trade adversely affects the global economy and the viability of some countries that have become transit routes.

The huge sums of illegal money generated by the drug trade encourage money laundering and have become inextricably linked with other international organised criminal activities such as terrorism, human trafficking, prostitution and the arms trade. Drug Lords have subverted the democratic governments of some countries to the great detriment of law abiding citizens.

Drug abuse has had a major adverse effect on global health and the spread of communicable diseases such as AIDS/HIV. Control is vitally important for the protection of communities against these problems. There is international agreement in the UN Conventions that drugs should be produced legally under strict supervision to ensure adequate supplies only for medical and research purposes. The cumulative effects of prohibition and interdiction combined with education and treatment during 100 years of international drug control have had a significant impact in stemming the drug problem. Control is working and one can only imagine how much worse the problem would have become without it. For instance:

• In 2007, drug control had reduced the global opium supply to one-third the level in 1907 and even though current reports indicate recent increased cultivation in Afghanistan and production in Southeast Asia, overall production has not increased.

• During the last decade, world output of cocaine and amphetamines has stabilized; cannabis output has declined since 2004; and opium production has declined since 2008. We, therefore, strongly urge nations to uphold and enhance current efforts to prevent the use, cultivation, production, traffic, and sale of illegal drugs. We further urge our leaders to reject the legalisation of currently illicit drugs as an acceptable solution to the world’s drug problem because of the following reasons:

• Only 6.1% of people globally between the ages of 15 and 64 use drugs (World Drug Report 2011 UNODC) and there is little public support for the legalisation of highly dangerous substances. Prohibition has ensured that the total number of users is low because legal sanctions do influence people’s behaviour.

• There is a specific obligation to protect children from the harms of drugs, as is
evidenced through the ratification by the majority of United Nations Member States of the UN Convention on the Rights of the Child (CRC). Article 33 states that Member States “shall take all appropriate measures, including legislative, administrative, social and educational measures, to protect children from the illicit use of narcotic drugs and psychotropic substances as defined in the relevant international treaties, and to prevent the use of children in the illicit production and trafficking of such substances”.

• Legalisation sends the dangerous tacit message of approval, that drug use is
acceptable and cannot be very harmful.

• Permissibility, availability and accessibility of dangerous drugs will result in
increased consumption by many who otherwise would not consider using them.

• Enforcement of laws creates risks that discourage drug use. Laws clearly define what is legal and illegal and emphasise the boundaries.

• Legalisation would increase the risks to individuals, families, communities and world regions without any compensating benefits.

• Legalisation would remove the social sanctions normally supported by a legal system and expose people to additional risk, especially the young and vulnerable.

• The legalisation of drugs would lead inevitably to a greater number of dependencies and addictions likely to match the levels of licit addictive substances. In turn, this would lead to increasing related morbidity and mortality, the spread of communicable diseases such as AIDS/HIV and the other blood borne viruses exacerbated by the sharing of needles and drugs paraphernalia, and an increased burden on the health and social services.

• There would be no diminution in criminal justice costs as, contrary to the view held by those who support legalisation, crime would not be eliminated or reduced. Dependency often brings with it dysfunctional families together with increased domestic child abuse.

• There will be increases in drugged driving and industrial accidents.

• Drug Control is a safeguard protecting millions from the effects of drug abuse and addiction particularly, but not exclusively, in developing countries.

• Statements about taxation offsetting any additional costs are demonstrably flawed and this has been shown in the case of alcohol and tobacco taxes. Short of governments distributing free drugs, those who commit crime now to obtain them would continue to do so if they became legal.

• Legalisation would not take the profit out of the drug trade as criminals will always find ways of countering legislation. They would continue their dangerous activities including cutting drugs with harmful substances to maximise sales and profits. Aggressive marketing techniques, designed to promote increased sales and use, would be applied rigorously to devastating effect.

• Other ‘legal’ drugs – alcohol and tobacco, are regularly traded on the black market and are an international smuggling problem; an estimated 600 billion cigarettes are smuggled annually (World Drug report 2009). Taxation monies raised from these products go nowhere near addressing consequential costs.

• Many prisons have become incubators for infection and the spread of drug related diseases at great risk to individual prisoners, prison staff and the general public. Failure to eliminate drug use in these institutions exacerbates the problem.

• The prisons are not full of people who have been convicted for mere possession of drugs for personal use. This sanction is usually reserved for dealers and those who commit crime in the furtherance of their possession.

• The claim that alcohol and tobacco may cause more harm than some drugs is not a pharmacokinetics of psychotropic substances suggest that more, not less, control of their access is warranted.

• Research regularly and increasingly demonstrates the harms associated with drug use and misuse. There is uncertainty, yet growing evidence, about the long-term detrimental effects of drug use on the physical, psychological and emotional health of substance users.

• It is inaccurate to suggest that the personal use of drugs has no consequential and damaging effects. Apart from the harm to the individual users, drugs affect others by addiction, violence, criminal behaviour and road accidents. Some drugs remain in the body for long periods and adversely affect performance and behaviour beyond the time of so-called ‘private’ use. Legalisation would not diminish the adverse effects associated with drug misuse such as criminal, irrational and violent behaviour and the mental and physical harm that occurs in many users.

• All drugs can be dangerous including prescription and over the counter medicines if they are taken without attention to medical guidance. Recent research has confirmed just how harmful drug use can be and there is now overwhelming evidence (certainly in the case of cannabis) to make consideration of legalisation irresponsible.

• The toxicity of drugs is not a matter for debate or a vote. People are entitled to their own opinions but not their own facts. Those who advocate freedom of choice cannot create freedom from adverse consequences.

• Drug production causes huge ecological damage and crop erosion in drug producing areas.

• Nearly every nation has signed the UN Conventions on drug control. Any government of signatory countries contemplating legalisation would be in breach of agreements under the UN Conventions which recognise that unity is the best approach to combating the global drug problem. The administrative burden associated with legalisation would become enormous and probably unaffordable to most governments. Legalisation would require a massive government commitment to production, supply, security and a bureaucracy that would necessarily increase the need for the employment at great and unaffordable cost for all of the staff necessary to facilitate that development.

• Any government policy must be motivated by the consideration that it must first do no harm. There is an obligation to protect citizens and the compassionate and sensible method must be to do everything possible to reduce drug dependency and misuse, not to encourage or facilitate it. Any failures in a common approach to a problem would result in a complete breakdown in effectiveness. Differing and fragmented responses to a common predicament are unacceptable for the wellbeing of the international community. It is incumbent on national governments to cooperate in securing the greatest good for the greatest number.

ISSUED this 21st day of December, 2011 by the following groups:
Drug Prevention Network of the Americas (DPNA)
Institute on Global Drug Policy
International Scientific and Medical Forum on Drug Abuse
International Task Force on Strategic Drug Policy
People Against Drug Dependence & Ignorance (PADDI), Nigeria
Europe Against Drugs (EURAD)
World Federation Against Drugs (WFAD)
Peoples Recovery, Empowerment and Development Assistance (PREDA)
Drug Free Scotland

Following the Scottish example, England has piloted drug courts using specially trained magistrates to closely supervise treatment-based community sentences. This initial report found no major glitches but low throughput and uncertain cost-benefits.

Summary The Dedicated Drug Court framework for England and Wales provides for specialist courts which exclusively handle cases relating to drug misusing offenders from conviction through sentence to completion (or breach) of a community order with a Drug Rehabilitation Requirement (DRR). Two magistrates’ courts (Leeds Magistrates’ Court and West London Magistrates’ Court) have been piloting drug courts implemented in line with the Ministry of Justice’s framework.

The critical factors for implementation success are an understanding of local context and scale of need, the enthusiasm of the local judiciary and partner agencies, good partnership working, availability of resources to deliver the drug court and its associated treatment services, the depth of understanding by all staff of offender motivation and, in particular, recognition of the points at which an offender is most likely to make progress in reducing or stopping drug use. Continuity of judiciary is key to successful implementation of a drug court. It provides the focus for communication between the court and the offender and across magistrate panels. Continuity of judiciary was a strong planned feature of both courts. Based on analysis undertaken with data from the Leeds pilot, there is strong evidence that continuity of magistrates has a statistically significant impact on several key drug court outcomes. Greater continuity of magistrates experienced by offenders is associated with their being less likely to miss a court hearing, more likely to complete their sentence, and less likely to be reconvicted.

Break-even analysis showed that (compared to normal adjudication) an extra 8% of offenders seen by the courts would need to stop taking drugs for five years or more following completion of the sentence to provide a net economic benefit to the wider society, and 14% in order to provide a net economic benefit to the criminal justice system. A robust quantification of impact was not possible because of the difficulties in collecting sufficient data on a comparison group of offenders not processed through drug courts.

Findings Commissioned by the UK Ministry of Justice, the report describes the implementation rather than the outcomes of England’s pilot drug courts. In line with international understandings, the courts were intended to specialise in drug-related offenders, presided over by sentencers specially trained for this task who order treatment-based sentences and closely supervise the offender’s progress, aided by regular tests for illegal drug use. The aim is maximise the rehabilitative impact of the sentence by increasing compliance and engagement with treatment through criminal justice pressure (ultimately the prospect of receiving a more typical punishment-based sentence if the drug court’s order fails) and rewards (of which one of the most powerful seems to be the unfamiliar experience of being congratulated by a judge or magistrate).

The report identified no critical fault lines in the implementation of the courts. However, these were particularly promising sites: the Leeds court built on a pre-existing system and in London, court staff were enthusiastic about the proposal and had already been working towards creating a drug court. Nevertheless, offender throughput was lower than expected. Over the 17 months of the evaluation, the London court sentenced just 60 new offenders while in Leeds the total was 276. Low throughput raised costs per offender. Compared to a standard 12-month drug rehabilitation requirement order implemented through normal adjudication, supervising the order through the drug courts cost £4633 extra per offender.

With no comparison group of normally adjudicated offenders, the evaluation was unable to say whether this was money well spent. They were, however, able to calculate the drug use reductions the courts would have to ‘buy’ in order to meet their extra costs – as noted in the abstract, the answer was 8% of offenders ceasing drug use for at least five years compared to the numbers doing so on a normally adjudicated drug rehabilitation requirement order. This calculation though excludes the base costs of normal adjudication and of a normally supervised drug rehabilitation requirement order. This seems to mean that the 8% would also have to be over and above the proportion of offenders who remain abstinent after normal judicial processing. The report gives no indication of how much success would be needed to match the total costs incurred by the criminal justice system in implementing all the elements of a drug court-supervised drug rehabilitation requirement order.

The report’s emphasis on offenders seeing the same magistrate(s) for their sentencing and throughout subsequent progress reviews is backed by evidence from Leeds that continuity is substantially associated with better compliance and drug use and crime outcomes. Steps were taken to reduce the risk that continuity was caused by high compliance and good progress rather than vice versa. However, without actually allocating offenders at random to see or not see the same magistrates, it is impossible to eliminate this possibility. Assuming the effect was real, it is of concern that organising continuity was a challenge, and especially so for ‘breach’ hearings dealing with unacceptable failures to comply with the order, which national regulations required to occur within a set period. Unfortunately, these crucial junctures are just when continuity is most needed, requiring an understanding of whether the offender will do better on a revised order, or the order has failed and should be revoked, often resulting in imprisonment.

A final caution over any such report is that some leading criminologists accuse the UK government of manipulating and distorting criminological research for political gain, to the point where the professor of criminology at the Open University has called for a boycott of government-commissioned work. The featured report was commissioned by the UK Ministry of Justice, a ministry carved out in part from the Home Office, one of the main targets of these accusations.

Scotland preceded England in formally piloting drug courts in Glasgow from 2001 and in Fife the following year. As in England, implementation was not entirely smooth but better than might have been expected. There was a high but it was thought acceptable failure rate, probably aided by Scotland’s more flexible application of drug treatment and testing orders, predecessors to the drug rehabilitation requirements used later by the English courts. However, crime impacts were questionable. Within one year 50% of drug court offenders had been reconvicted and within two years 71%, and the average frequency of reconvictions only slightly dipped in the two years after the order was imposed compared to the two years before. There was no clear crime-reduction benefit from supervising the orders through the drug courts (at an average cost of nearly £18,500 per order) as opposed to normal adjudication. But, as in England, the costs imposed on society by persistent, high-rate offending and drug-related mortality and morbidity, are such that even modest improvements might be cost-beneficial overall.

International experience and research relating to drug courts suggests it is important for courts to emphasise rewards as well as punishments, see offenders frequently enough to apply these swiftly in response to progress, deploy a range of rewards and sanctions short of revocation which are consistently applied, have a strong and sure ultimate sanction when the programme fails, make these consequences absolutely clear to offenders, have rapid access to a range of treatment options, maintain continuity in the judge dealing with the case, and to attend to the range of the individual’s needs. Willingness to continue despite some initial offending makes the structure imposed by stringent requirements and monitoring a positive feature rather than one which leads most offenders to fail. Consistent judicial supervision, the fact that this forces addicts (back) in to treatment, and drug testing which provides a shared measure of how treatment is progressing, probably all play their parts.

Source: www.findings.org.uk March 2009

Illegal drugs not only harm a user’s mind and body, they devastate families, communities, and neighborhoods. They jeopardize public safety, prevent too many Americans from reaching their full potential, and place obstacles in the way of raising a healthy generation of young people.

To address these challenges, today we are releasing the 2012 National Drug Control Strategy — the Obama Administration’s primary policy blueprint for reducing drug use and its consequences in America. The President’s inaugural National Drug Control Strategy, published in 2010, charted a new direction in our approach to drug policy. Today’s strategy builds upon that approach, which is based on science, evidence, and research. Most important, it is based on the premise that drug addiction is a chronic disease of the brain that can be prevented and treated. Simply put, we are not powerless against the challenge of substance abuse — people can recover, and millions are in recovery. These individuals are our neighbors, friends and family members. They contribute to our communities, our workforce, our economy, and help make America stronger.

Our emphasis on addressing the drug problem through a public health approach is grounded in decades of research and scientific study. There is overwhelming evidence that drug prevention and treatment programs achieve meaningful results with significant long-term cost savings. In fact, recent research has shown that each dollar invested in an evidence-based prevention program can reduce costs related to substance use disorders by an average of $18.

But reducing the burden of our nation’s drug problem stretches beyond prevention and treatment. We need an all of the above approach. To address this problem in a comprehensive way, the President’s new strategy also applies the principles of public health to reforming the criminal justice system, which continues to play a vital role in drug policy. It outlines ways to break the cycle of drug use, crime, incarceration, and arrest by diverting non-violent drug offenders into treatment, bolstering support for reentry programs that help offenders rejoin their communities, and advancing support for innovative enforcement programs proven to improve public health while protecting public safety.

Together, we have achieved significant reform in the way we address substance abuse. And the Affordable Care Act will — for the first time — require insurers to cover treatment for drug addiction the same way they would other chronic diseases. This is a revolutionary shift in how we address drug policy in America.
Over the past three decades, we have reduced illegal drug use in America. Over the long term, rates of drug use among young people today are far lower than they were 30 years ago. More recently cocaine use has dropped nearly 40 percent and meth use has dropped by half. And we can do more. As President Obama has noted, we have successfully changed attitudes regarding rates of smoking and drunk driving, and with your help we can do the same with our illegal drug problem.

Source: R. Gil Kerlikowske
Director, White House Office of National Drug Control Policy 18th April 2012

The fashionable party drug mephedrone has been linked to up to 98 recent deaths in Britain, the Government’s advisers warned last night, as they called for tougher action to combat the proliferation of legal highs.

The Advisory Council on the Misuse of Drugs (ACMD) said unscrupulous manufacturers made a mockery of the law by falsely advertising addictive substances as “plant food” or “bath salts”. Its chairman, Professor Les Iverson, warned young users of “designer drugs” were playing “Russian roulette” with their lives – and said the effects were already being seen in hospitals. He said: “We are not seeing just a nice party drug but something that can kill.”

Prof Iverson released figures showing that in the past two years mephedrone had been confirmed as a factor in 42 deaths and had not been ruled out as contributing to another 56.
Users of designer drugs – created in labs to mimic the make-up of banned substances such as ecstasy and amphetamines – suffered such extreme side-effects that they had to be sedated. They had also been treated for paranoia, psychosis, high heart rates and raised blood pressure, he said. He added: “Users are playing Russian roulette. They are buying substances marked as research chemicals. The implication is that you should do the research on yourself to find out whether they’re safe or not. This is a totally uncontrolled, unregulated market.”

The first large quantities of legal highs, or psychoactive drugs – many made in China – appeared in Britain two years ago. They can be easily bought online or from shops selling drug paraphernalia and herbal goods. Some undergraduates also sell them to fellow students. The ACMD said: “Many people importing these new substances appear to have had no previous involvement in the illicit drug trade and are just in it to make a quick buck. They have included students who have set up websites to supply nationally and who also supply the local student population.”

Ministers have outlawed several such substances, but the ACMD warned that producers were sidestepping the bans by tweaking the composition of drugs. It backed creating a new system of broader bans in which all substances chemically similar to controlled drugs were automatically made illegal. The ACMD also called for suppliers to have to demonstrate that legal highs were not being produced for human consumption and for a fresh drive to alert the public to their dangers.

Roger Howard, chief executive of the UK Drug Policy Commission, backed the proposals. He said: “We have rapidly growing numbers of psychoactive drugs on the market and it’s increasingly difficult for police to identify the different drugs they are finding.”

The Home Office said it was considering the recommendations and added: “The Government is leading the way in cracking down on legal highs by outlawing not just individual drugs but whole families of related substances.”

By numbers…
2009 The year police made first seizure of mephedrone. It was banned in 2010.
£15 Approximate price of a gram before it was classified.
98 The number of deaths recently linked to mephedrone.

Source: The Independent 26th October

Parents of teenagers’ friends can have as much effect on the teens’ substance use as their own parents, according to a new study.

“Among friendship groups with ‘good parents’ there’s a synergistic effect – if your parents are consistent and aware of your whereabouts, and your friends’ parents are also consistent and aware of their (children’s) whereabouts, then you are less likely to use substances,” said Michael J. Cleveland, research assistant professor at the Prevention Research Centre and the Methodology Centre, Penn State.

In the study, 9,417 ninth-grade students were surveyed during the spring semester, and then again the following spring semester. The subjects came from 27 different rural school districts in Pennsylvania and Iowa, all participating in the Promoting School-university-community Partnerships to Enhance Resilience (PROSPER) study.

In ninth grade, the students were asked to name five of their closest friends. The researchers then identified social networks within the schools by matching up the mutually exclusive friendships. Overall, the team identified 897 different friendship groups, with an average of 10 to 11 students in each group.

At that time students also responded to questions about their perceptions of how much their parents knew about where they were and who they were with. They were also asked about the consistency of their parents’ discipline.

In the tenth-grade follow-up, participants answered questions about their substance use habits, specifically their use of alcohol, cigarettes and marijuana.

Researchers found parenting behaviours and adolescents’ substance-use behaviours to be significantly correlated that higher levels of parental knowledge and disciplinary consistency leading to a lower likelihood of substance use, whereas lower levels lead to a higher likelihood of substance use.

It was also found that behaviours of friends’ parents influenced substance use even when taking into account the effects of the teens’ own parents’ behaviours and their friends’ substance use, demonstrating the powerful effect of peers on adolescent behaviour

For example, if adolescents’ parents are consistent and generally aware of their children’s activities, but the parents of the children’s friends are inconsistent and generally unaware of their own children’s activities, the adolescents are more likely to use substances than if their friends’ parents were more similar to their own parents.

“The peer context is a very powerful influence,” said Cleveland. “We’ve found in other studies that the peer aspect can overwhelm your upbringing.”

According to the authors, this to be the first study where parenting at the peer level proved to have a concrete and statistically significant impact on child outcomes.

“I think that it empowers parents to know that not only can they have an influence on their own children, but they can also have a positive influence on their children’s friends as well,” said Cleveland. “And that by acting together the notion of ‘it takes a village’ can actually result in better outcomes for adolescents.”

The study was published in this month’s issue of the Journal of Studies on Alcohol and Drugs.

Filed under: Parents :

While prescription drug abuse has been a major public health concern for several years, the public health and public safety consequences of prescription drug abuse continue to mount. National data show that in 2009 the 39,147 drug-induced deaths exceeded deaths from motor vehicle crashes (36,216). In 2008, the latest year for which national data are available, there were 20,044 unintentional prescription drug overdose deaths. The problem of prescription drug abuse is particularly acute in the southern United States and the Appalachian region. Prescription drugs caused an average of seven deaths per day in Florida in 2010, according to the Florida Medical Examiners Commission Drug Report.”

Source: http://www.whitehouse.gov/ondcp/2012-national-drug-control-strategy)

While it’s important for all of us to maintain our focus on illicit drugs of abuse, it’s also important to recognize that diverted prescription drugs, principally opioids, are estimated to cause more overdose deaths each year in the US than heroin, cocaine, and methamphetamine – combined! Moreover, the figure of 20,044 “unintentional prescription drug overdose deaths” mentioned in the recent ONDCP Strategy Report (supra) in all likelihood represents an undercount. This death tally is computed by the Centers for Disease Control and Prevention (CDC) from death certificates filed by state medical examiners. Researchers, however, have criticized this dataset for its limitations. Wysowski (2007), for example, conducted a surveillance study of 25,031 deaths attributed to prescription drugs in 2003 and compared this with a total of 16,135 similar deaths reported for 1999. She used the aforementioned CDC data base that transfers data from death certificates to categories known as the ICD-10 codes, designed in accordance with the International Classification of Diseases (10th revision). Wysowski commented on the limitations of these data:

Drug names also are absent from death certificates because of certifiers’ under-attribution of drug-related deaths. Certifiers of death may not recognize a drug as a cause or, or as contributing to, a patient’s death, and when they do, they sometimes write ‘adverse drug reaction’ without providing the name of the drug on the death certificate. Furthermore, toxicological data are often unavailable at the time of death certification although death certificates can be amended to include subsequent information.”

Source: (Ref: Wysowski DK. Surveillance of prescription drug-related mortality using death certificate data. Drug Saf. 2007;30(6):533-540

Filed under: Health,USA :

The two pals are believed to have taken deadly GBL, a solvent found in paint strippers and chillingly known on the club scene as “coma in a bottle”

A heartbroken mum yesterday warned that Britain faces a new epidemic after banned party drug GBL was blamed for killing two friends within hours.

Carl Fearon, 24, was found dead at his flat at about 1pm on Saturday afternoon.

Just eight hours later, mum-of-one Lynette Nock, 28, died at a memorial wake held by his friends.

The two pals are believed to have taken deadly GBL, a solvent found in paint strippers and chillingly known on the club scene as “coma in a bottle”.

The tragedy comes exactly three years after medical student Hester Stewart, 21, was found dead at a house in Brighton after a party.

Police found a bottle of GBL next to her body.

Hester’s mum Maryon Stewart, who went on to launch drug awareness charity the Angelus Foundation, said yesterday: “They are not drugs, they are chemicals and when you take them you’re playing Russian Roulette with your life.

But you can’t control something like paint stripper because it has legitimate uses. When you ban one of these things probably a dozen others pop up to replace it.

“Last year 49 new substances appeared and no one really knows what’s in them. This is a major epidemic.

 “The Home Office should be taking responsibility to protect young people and raise awareness. There were directives from Europe 18 months before Hester died but nothing was done.’

 “Sadly, the message has still not filtered through and the same thing has happened and I’m deeply saddened.”

Electrical engineer Carl was found dead at his flat in Birmingham . Friends said he collapsed after taking GBL the previous night.

When word of his death spread, pals hosted a wake at a house in the city on Saturday night at which accountant Lynette collapsed.

Neighbour Emma Heath, 24, said: “I heard they put it in a Fanta bottle and several of them ended up being taken to hospital.” Lynette’s heartbroken father Dave, 69, yesterday paid tribute to his daughter and called for something to be done about GBL, describing it as “a lethal drug, a killer”. He says he fears Lynette’s drink may have been spiked, adding: “If Lynette had GBL in her system, did she and the others at that party ingest it without knowing what they were taking? Was it that their drink was spiked? From what I’ve read, this GBL has no taste and no smell.”

Det Insp Andy Hawkins said: “We believe the controlled substance Gamma-Butyrolactone, or GBL, may have been used as a drug at the gathering.” A spokesman for drugs charity FRANK said: “GBL is a dangerous drug with sedative and anaesthetic effects that can produce feelings of euphoria and can cause drowsiness. “It can kill.”

“It can do almost anything”: Analysis by drugs policy expert Dr Jonathan Cave

THE body converts GBL to date rape drug GHB, and because of how it is converted, GBL takes effect more quickly. It’s often advertised as a nutritional supplement but is harmful. GBL is unpredictable because it can do almost anything. It can have a mild effect, give people a headache or in some cases do a lot worse. It’s not directly toxic but the people to whom it is toxic won’t know until they take it. Some get addicted and take it 24 hours a day.

GBL, or Gamma-Butyrolactone, is known as “coma in a bottle”. It is used as paint stripper and was banned for consumption in 2009.

GBL is odourless and tasteless when diluted and is sold online for as little as 50p a shot.

The effect is similar to ecstasy but there is a high risk of overdosing.  Some users say it feels as if their muscles are being torn apart.  Medics say it kills six a year, damages organs and leads to psychosis.  It is related to banned date rape drug GHB.

Source:  www.Mirror.co.uk  2 May 2012

 

 


 

More than 20 cannabis farms and factories were discovered by police every day last year as they seized drugs which could sell for £100 million on the streets, figures showed today.

Senior police chiefs said the size and scale of the farms were reducing as criminals producing cannabis were spreading the risk and minimising losses by employing a large number of so-called gardeners to manage small sites across multiple residential areas.

Over the two years since the last report by the Association of Chief Police Officers (Acpo), some 1.1 million plants have been seized with a street value of £207.4 million.

A total of 7,865 farms were found across the UK in 2011/12, up 15% from 6,866 in 2009/10 and more than a 150% increase from the 3,032 identified four years ago, the study by the Association of Chief Police Officers (Acpo) found.

There has been a “move back to the use of residential property” and dismantling factories was seen as “a short term solution, with missed opportunities for further investigation into potentially linked factories”, the police chiefs said.

The number of offences related to cannabis production is also increasing, up from 14,982 in 2010/11 to 16,464 last year.

Scotland Yard Commander Allan Gibson, the lead on cannabis cultivation for the police chiefs, said: “Commercial cannabis cultivation continues to pose a significant risk to the UK .

Increasing numbers of organised crime groups are diverting into this area of criminality but we are determined to continue to disrupt such networks and reduce the harm caused by drugs.

This profile provides a detailed analysis of the current threat from commercial cultivation of cannabis and the work undertaken by law enforcement agencies to combat the threat.”

The highest number of farms (936) were found in the West Yorkshire force area, equivalent to 42 factories per 100,000 people, the Acpo figures showed.

But South Yorkshire had 64 farms per 100,000 people, the highest ratio in the UK , with 851 farms.

The two forces were followed by other heavily-populated force areas, including West Midlands (663 farms, or 25 per 100,000 people), the Metropolitan Police (608 farms, or eight per 100,000 people) and Avon and Somerset (653 farms, or 40 per 100,000 people).

But the Devon and Cornwall force recorded the highest rise in the number of farms since the last report in 2009/10, with the number of farms identified rising 1,664% from 11 to 183 (11 farms per 100,000 people)

Source: www.Independent.co.uk  30th April 2012


In human populations, cigarettes and alcohol generally serve as gateway drugs, which people use first before progressing to marijuana, cocaine, or other illicit substances. To understand the biological basis of the gateway sequence of drug use, we developed an animal model in mice and used it to study the effects of nicotine on subsequent responses to cocaine. We found that pretreatment of mice with nicotine increased the response to cocaine, as assessed by addiction-related behaviors and synaptic plasticity in the striatum, a brain region critical for addiction-related reward. Locomotor sensitization was increased by 98%, conditioned place preference was increased by 78%, and cocaine-induced reduction in long-term potentiation (LTP) was enhanced by 24%. The responses to cocaine were altered only when nicotine was administered first, and nicotine and cocaine were then administered concurrently. Reversing the order of drug administration was ineffective; cocaine had no effect on nicotine-induced behaviors and synaptic plasticity. Nicotine primed the response to cocaine by enhancing its ability to induce transcriptional activation of the FosB gene through inhibition of histone deacetylase, which caused global histone acetylation in the striatum. We tested this conclusion further and found that a histone deacetylase inhibitor simulated the actions of nicotine by priming the response to cocaine and enhancing FosB gene expression and LTP depression in the nucleus accumbens. Conversely, in a genetic mouse model characterized by reduced histone acetylation, the effects of cocaine on LTP were diminished. We achieved a similar effect by infusing a low dose of theophylline, an activator of histone deacetylase, into the nucleus accumbens. These results from mice prompted an analysis of epidemiological data, which indicated that most cocaine users initiate cocaine use after the onset of smoking and while actively still smoking, and that initiating cocaine use after smoking increases the risk of becoming dependent on cocaine, consistent with our data from mice. If our findings in mice apply to humans, a decrease in smoking rates in young people would be expected to lead to a decrease in cocaine addiction.

Source:  Science Translational Medicine 2 November 2011:
Vol. 3, Issue 107, p. 107ra109



 

 

 

West, R., et al. (2011)

This important study assessed the effectiveness of the drug cytisine in smoking cessation programs, and a potential star was born. In a single-center, randomized, double-blind, placebo-controlled trial, the journal paper concluded that “cytisine was more effective than placebo for smoking cessation. The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally.”

 

 Source: New England Journal of Medicine 365: 1193-1200. 2011

 


 



 

Filed under: Addiction :

Even smart people make mistakes, sometimes surprisingly large ones.  A current example is drug legalization, which way too many smart people consider a good idea.  They offer three bad arguments.

First, they contend, “the drug war has failed”, despite years of effort we have been unable to reduce the drug problem.  Actually, as imperfect as surveys may be, they present overwhelming evidence that the drug problem is growing smaller and has fallen in response to known, effective measures.  Americans use illegal drugs at substantially lower rates than when systematic measurement began in 1979, down almost 40 percent.  Marijuana use is down by almost half since its peak in the late 1970s, and cocaine use is down by 80 percent since its peak in the mid-1980s.  Serious challenges with crack, meth, and prescription drug abuse have not changed the broad overall trend: Drug use has declined for the last 40 years, as has drug crime.

The decades of decline coincide with tougher laws, popular disapproval of drug use, and powerful demand reduction measures such as drug treatment in the criminal justice system and drug testing.  The drop also tracks successful attacks on supply, as in the reduction of cocaine production in Colombia and the successful attack on meth production in the United States.  Compared with most areas of public policy, drug control measures are quite effective when properly designed and sustained.

Drug enforcement keeps the price of illegal drugs at hundreds of times the simple cost of producing them.  To destroy the criminal market, legalization would have to include a massive price cut, dramatically stimulating use and addiction.  Legalization advocates typically ignore the science.  Risk varies a bit, but all of us and a variety of other living things, monkeys, rats, and mice, can become addicted if exposed to addictive substances in sufficient concentrations, frequently enough, and over a sufficient amount of time.  It is beyond question that more people using drugs, more frequently, will result in more addiction.

About a third of illegal drug users are thought to be addicted (or close enough to it to need treatment), and the actual number is probably higher.  There are now at least 21 million drug users, and at least 7 million need treatment.  How much could that rise?  Well, there are now almost 60 million cigarette smokers and over 130 million who use alcohol each month.  It is irrational to believe that legalization would not increase addiction by millions.  

We can learn from experience.  Legalization has been tried in various forms, and every nation that has tried it has reversed course sooner or later.  America’s first cocaine epidemic occurred in the late 19th century, when there were no laws restricting the sale or use of the drug.  That epidemic led to some of the first drug laws, and the epidemic subsided.  Over a decade ago the Netherlands was the model for legalization.  However, the Dutch have reversed course, as have Sweden and Britain (twice).  The newest example for legalization advocates is Portugal, but as time passes the evidence there grows of rising crime, blood-borne disease, and drug usage.

The lessons of history are the lessons of the street. Sections of our cities have tolerated or accepted the sale and use of drugs.  We can see for ourselves that life is not the same or better in these places, it is much worse.  If they can, people move away and stay away.  Every instance of legalization confirms that once you increase the number of drug users and the addicted, it is difficult to undo your mistake.

The most recent form of legalization, pretending smoked marijuana is medicine, is following precisely the pattern of past failure.  The majority of the states and localities that have tried it are moving to correct their mistake, from California to Michigan.  Unfortunately, Washington, D.C., is about to start down this paths.  It will end badly.

The second false argument for legalization is that drug laws have filled our prisons with low-level, non-violent offenders.  The prison population has increased substantially over the past 30 years, but the population on probation is much larger and has grown almost as fast.  The portion of the prison population associated with drug offences has been declining, not growing. The number of diversion programs for substance abusers who commit crimes has grown to such an extent that the criminal justice system is now the single largest reason Americans enter drug treatment.

Despite constant misrepresentation of who is in prison and why, the criminal justice system has steadily and effectively focused on violent and repeat offenders. The unfortunate fact is that there are too many people in prison because there are too many criminals. With the rare exceptions that can be expected from human institutions, the criminal justice system is not convicting the innocent.

Most recently, crime and violence in Central America and Mexico have become the third bad reason to legalize drugs.  Even some foreign leaders have joined in claiming that violent groups in Latin America would be substantially weakened or eliminated if drugs were legal.

Many factors have driven this misguided argument.  First, while President Álvaro Uribe in Colombia and President Felipe Calderón in Mexico demonstrated brave and consequential leadership against crime and terror, such leadership is rare.  For both the less competent and the corrupt, the classic response in politics is to blame someone else for your failure.

The real challenge is to establish the rule of law in places that have weak, corrupt, or utterly inadequate institutions of justice.  Yes, the cartels and violent gangs gain money from the drug trade, but they engage in the full range of criminal activities, murder for hire, human trafficking, bank robbery, protection rackets, car theft, and kidnapping, among others.  They seek to control areas and rule with organized criminal force.  This is not a new phenomenon, and legalizing drugs will not stop it.  In fact, U.S. drug laws are a powerful means of working with foreign partners to attack violent groups and bring their leaders to justice.

Legalization advocates usually claim that alcohol prohibition caused organized crime in the United States and its repeal ended the threat.  This is widely believed and utterly false.  Criminal organizations existed before and after prohibition.  Violent criminal organizations exist until they are destroyed by institutions of justice, by each other, or by authoritarian measures fueled by popular fear.  No honest criminal justice official or family in this hemisphere will be safer tomorrow if drugs are legalized, and the serious among them know it.

Are the calls for legalization merely superficial, silly background noise in the context of more fundamental problems?  Does this talk make any difference? Well, suppose someone you know said, “Crack and heroin and meth are great, and I am going to give them to my brothers and sisters, my children and my grandchildren.”  If you find that statement absurd, irresponsible, or obscene, then at some level you appreciate that drugs cannot be accepted in civilized society.  Those who talk of legalization do not speak about giving drugs to their families, of course; they seem to expect drugs to victimize someone else’s family.

Irresponsible talk of legalization weakens public resolve against use and addiction.  It attacks the moral clarity that supports responsible behavior and the strength of key institutions.  Talk of legalization today has a real cost to our families and families in other places.  The best remedy would be some thoughtful reflection on the drug problem and what we say about it.

Source: http://www.weeklystandard.com/author/john-p.-walters 7th May 2012

A word of warning to parents of adolescents, from the nation’s poison centers:  Yes, you’ve secured your medicine chest and your liquor cabinet, but a new thrill-seeking activity among teens might make you consider locking away the cinnamon shaker as well.

 In the first three months of 2012, the nation’s poison centers have had 139 calls—close to three times as many as were received in all of 2011—seeking help and information about the intentional misuse of cinnamon.  At least 122 of these calls arose from something called the “cinnamon challenge”—a game growing in popularity among teens in which a child is dared to swallow a spoonful of ground or powdered cinnamon without drinking any water.

 As cinnamon coats and dries the mouth and throat, coughing, gagging, vomiting and inhaling of cinnamon ensures, leading to throat irritation, breathing difficulties and risk of pneumonia, says Dr. Alvin C. Bronstein, medical and managing director of Rocky Mountain Poison and Drug Center.   For teens who suffer from asthma, the “cinnamon challenge” can be particularly risky, because they can develop shortness of breath.

 Of the 139 calls received so far this year by poison control centers, 30 required medical evaluation.  What started kids abusing the contents of the kitchen’s little bear shaker?  Look no further than the internet:  Videos posted there are helping spread word of the cinnamon challenge.

 “We urge parents and caregivers to talk to their teens about the cinnamon challenge, explaining to their teens that what may seem like a silly game can have serious health consequences,” said Bronstein.

 The latest warning comes out of the American Association of Poison Control Centers’ National Poison Data System, which collects data on some 2 million calls made to poison control lines across the country each year, providing early warning of dangerous trends.

 Source:  ErieTimes News  – USA    2nd April 2012

Filed under: Parents :

This letter is from Dr. Pinto Coelho from Portugal – his English is not perfect but the gist of the paper is very clear .. i.e. the media claims that decriminalisation in Portugal has been successful are simply not true.

The factual picture of Portuguese drug policy
Reaching out English Parliament and David Cameron
 

The Executive Office of the President Barak Obama Drug Control Policy, Director Gil Kerlikowske, in a letter to a member of the International Task Force on Strategic Drug Policy and Drug Watch International, is peremptory: “Our analysts found that claims that decriminalization has reduced drug use and had no detrimental impact in Portugal significantly exceed the existing scientific basis. Because this conclusion largely contradicts prevailing media coverage and several policy analyses in Portugaland the United States, my staff has heavily documented the sources of the data and information contained in this working paper. Please feel free to use this document in part or in whole to help strengthen your own efforts to advance a more honest discussion of decriminalization in Portugal and of the drug policy choices with nations are grappling today.”
 
This report is a consequence of a complete absurd campaign of an unacceptable manipulation of Portuguese drug policy facts and numbers, rose on the 33 pages of a so original as misleading book written by a writer/lawyer, Glenn Greenwald, fluent in Portuguese (on the eve of two important elections in Portugal), for the American “libertarian” think-tank Cato Institute –  a long time advocate of drug legalization.
 
That book, underestimating the readers’ understanding and suggesting the contrary to what the numbers show clearly and unequivocally, has been carried out unconscientiously and naively by some usually responsible national and international press all over the world that boosting the proliferation of the Portuguese “good news” are dangerously distorting the projection of the reality: “The Guardian” -“Britain looks at Portugal´s success story over decriminalizing personal drug use” (September 5th 2010), “The Economist” – “The evidence from Portugal since 2001 is that decriminalization of drug use and possession has benefits and no harmful side-effects” (August 27th 2009) and the Portuguese magazine “Visão” – “Portugal inspira Obama” (Maio 7, 2009) are just a few of the publications that mimicked the phenomena.
 
It was so effective that irreparable damages are already there – Czech Republic, Mexico and Argentina copied the Portuguese “good example” and did decriminalize drugs too…
 
That is the razing power of an attractive fallacy!
 
But lets go to the data (and his sources) and to that high representative USA official above letter: “Drug-induced deaths in Portugal that decreased from 369 in 1999 to 152 in 2003, climbed to 314 in 2007 – significantly more than the 280 deaths recorded when decriminalization started in 2001”. (EMCDDS, Statistical Bulletin 2009, Table DRD-2.)
 
“…the report´s claims of Portuguese drug legalization success, however it trumpets a decline in the lifetime prevalence rate for the 15-19 age group from 2001 to 2007, while discounting a larger lifetime prevalence increase in the 15-24 age group and ignoring the substantially larger lifetime prevalence increase in the 20-24 age group over the same period. (Greenwald, p.14.) Furthermore, the report emphasizes decreases in lifetime prevalence rates for the 13-18 age group from 2001 to 2006 and for heroin use in the 16-18 age group from 1999 to 2005, but once again downplays increases in the lifetime prevalence rates for the 15-24 age group between 2001 and 2006, and for the 16-18 age group between 1999 and 2005”. (Greenwald, pp. 12-14.)
 
“… despite an assertion in the Cato Institute report that increases in lifetime prevalence rates for a general population are “virtually inevitable in every nation”, EMCDDA data indicate that countries have been able to achieve decreases in lifetime prevalence rates, including Spain, for cannabis and ecstasy use between 2003 and 2008.” (EMCDDA, Statistical Bulletin 2009, Table GPS-1.)
 
To this painful data we must add:
 
“There is a notorious growing consumption of cocaine in Portugal, although not as severe as that which is verifiable in Spain. The increase in consumption of cocaine is extremely problematic”. (EMCDDA Executive Director, Wolfgang Gotz, Lisbon, May 2009.)
 
“While amphetamines and cocaine consumption rates doubled in Portugal, cocaine drug seizures have increased sevenfold between 2001 and 2006, rating Portugal the sixth highest in the world.” (World Drug Report, June 2009.)
 
“Behind Luxembourg, Portugal is the European country with the highest rate of consistent drug users and IV heroin dependents”. (Portuguese Drug Situation Annual Report, 2006)
 
“Portugal keeps on being the country with the most cases of injected drug related AIDS (85 new cases per one million of citizens in 2005, while the majority of other EU countries do not exceed 5 cases per million) and the only one registering a recent increase. 36 more cases per one million of citizens were estimated in 2005 comparatively to 2004, when only 30 were referred. It is the only country recording a recent increase. 703 newly diagnosed infections, followed from a distance by Estonia with 191 and Latvia with 108 reported cases.” (EMCDDA, November 2007.)
 
“The highest HIV/AIDS mortality rates among drug users are reported for Portugal, followed by Estonia, Spain, Latvia and Italy; in most other countries the rates are low” (EMCDDA – November 2010).
 
“In Portugal, since decriminalization has been implemented in July 2001, the number of drug related homicides has increased by 40%. It was the only European country with a significant increase between 2001 and 2006.” (World Drug Report, June 2009.)
 
This is the factual picture of Portuguese drug policy.
Unfortunately for drug dependent’ and their extended families and friends, a lie, as convenient as it could be, no matter how many times affirmed, no matter how insistently repeated, would never become the truth. So, “resounding success” seems a gross overestimate. It is rather simple and easy to grasp the reality of the facts, with one look at the real figures, the official figures.
Extraordinarily Mr. Greenwald managed to picture it otherwise and most of the world press bought it. Subsequently some governments disgracefully did too (USA fortunately didn’t) and others are pathetically wondering to “experiment the potential benefits of innovations like Portugal’s.” (“The Observer” Sunday 5 September 2010.) …
 
Manuel Pinto Coelho
Medical Doctor, Chairman of the Association for a Drug Free Portugal – member of World Family Organization and World Federation Against Drugs
Member of International Task Force on Strategic Drug Policy
Portugal Delegate of Drug Watch International
Portugal representative of European Cities Against Drugs
 
 
P.S.  I am political independent – I am not enrolled to any political party.
        I do not practice or have any links to any drug dependence facilities.

 

Filed under: Europe,Social Affairs :

   Adopted children are twice as likely to abuse drugs if their biological parents did too, suggesting that genetics do indeed play a role in the development of substance abuse problems.However, trouble or substance abuse in the adoptive family is also a risk factor, according to a study of more than 18,000 adopted children inSweden.

This suggests that both environment and biological family history can influence a child’s likelihood of future drug use.”For someone at low genetic risk, being in a bad environment conveys only a modestly increased risk of drug abuse,” says lead study author Dr. Kenneth S. Kendler, professor of psychiatry and human genetics at Virginia Commonwealth University in Richmond. “But if you are at high genetic risk, this can put your risk for drug abuse much higher.”

 The findings should be reassuring to adoptive parents, and to people who are thinking about adopting, because they show the importance of a positive environment, experts say.  “A child who is adopted, just like a child who is biological, does carry a certain genetic risk, but this shows that the environment they’re being raised in and how their genetic risk interacts with that is probably much more important for the potential development of any disease, including substance abuse and dependence,” says Dr. Lukshmi Puttanniah, director of child and adolescent psychiatry at Lenox Hill Hospital in New York, who was not involved with the study.

 The study, published this week in the Archives of General Psychiatry, included 18,115 children born inSwedenbetween 1950 and 1993 and later adopted. Overall, 4.5% of adopted individuals had drug-abuse problems as identified by Swedish medical, legal and pharmacy records, versus 2.9% of people in the general population.

But 8.6% of those who had at least one biological parent who abused drugs had their own abuse problems versus 4.2% of adoptees whose biological parents did not have a history of drug abuse.

 Adopted children had roughly double the risk of drug abuse if their biological full- or half-sibling had similar issues. But the risk was about the same if their adoptive siblings — those who had no biological connection to them — had abused drugs.

In general, trouble in the adoptive family, such as parental divorce, death, criminal activity, and alcohol problems was linked to a higher risk of drug abuse in the adopted child. There are a number of things adoptive parents — and biological parents for that matter — can do to minimize the risk of their children experimenting with drugs and alcohol, say experts.

“If parents are responsible, are monitoring their children’s behavior, paying attention to them, spending time with them, that’s going to have a positive effect and protect them from going down the path of alcohol and drug abuse,” says Maria M. Wong, Ph.D., associate professor of psychology at Idaho State University in Pocatello.

 “Knowing the medical history of children who will be adopted is always a good idea, however . . . genes are not destiny,” adds Dr. Wilson Compton, director of the division of epidemiology, services, and prevention research at the National Institute on Drug Abuse, which helped fund the study. “This study shows that in a healthy, safe, and secure environment with little exposure to drug abuse and other problems in the adoptive relatives, even children with multiple drug abusing biological relatives do much better than those whose adoptive families don’t provide such advantages.”

But the current study omitted some factors, some of which might be important to current and future adoptive parents.For instance, the researchers didn’t know when the adopted child joined his or her new family.

“Children who are adopted at age 5 are in a different risk category from newborns,” says Dr. Lisa Albers, director of the Adoption Program at Children’s Hospital Boston.

 And the study probably underestimates the number of drug users given that drug abuse was identified only if a person had had a brushwith the law, had been hospitalized or had a certain prescription history. That sets a “relatively high bar,” Albers says.  In any event, rates of drug abuse in theU.S.tend to be higher than inSwedenor other Scandinavian countries, says Kendler.  Also, researchers didn’t take into account changes in adoption in the last 50 years.

 For instance, many more children placed for adoption today have birth parents with a history of substance abuse compared with 50 years ago, says Albers.

On the other hand, the medical community has moved forward “light years” in its understanding and ability to handle other risk factors for substance abuse, such as ADHD, impulse control challenges, mental health concerns like anxiety or significant trauma, which may have occurred prior to the child coming into the family — all of which are risk factors for substance abuse, says Albers.

“If we have parents with a history of drug abuse, we can probably do better . . .. if we address the early signs that put the child at risk for drug abuse,” says Albers.

“Joining an adoptive family that is supportive even if you’re genetically at high risk is a very positive thing,” she adds.

Source:   www.health.com  5th March 2012

 

RANCHO CUCAMONGA, CA –  In new survey, 19 percent of teens admit to driving while under influence of marijuana, more than drunk driving. The survey, conducted by Liberty Mutual Insurance and Students Against Destructive Decisions (SADD), found that more teens are driving after smoking weed than after drinking alcohol. Only 13 percent of teens said they have driven after drinking. Read news release, click here.

Source:  paul@drugfreecalifornia.org  Feb.201

 

Back to top of page

Powered by WordPress